# Partners Calciphylaxis Biobank

> **NCT03032835** · — · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Calciphylaxis
- Calcific Uremic Arteriolopathy
- End Stage Renal Disease
- Chronic Kidney Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03032835
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2017-01
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03032835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03032835, "Partners Calciphylaxis Biobank". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03032835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*